Bio/Technology
1, 675 (1983)
doi:10.1038/nbt1083-675b
CorrespondenceHenry I. Miller1
1Henry I. Miller, M.D., National Center for Drugs and Biologics (HFN-823), FDA, 8800 Rockville Pike, Bethesda, MD 20205
REFERENCES
- Miller, H.I. 1981. The Impact of New Technology on Regulation by the FDA: Recombinant DNA Technology. Food, Drug, Cosmetic Law Journal 348: 351.
- Miller, H.I. 1982. The Impact of New Technology on Government Regulation: Recombinant DNA Technology and the U.S. Food and Drug Administration. In: From Genetic Experimentation to Biotechnology—the Critical Transition, W.J. Whelan and S. Black (eds.) John Wiley and Sons, New York.
- Miller, H.I. 1982. Recombinant DNA as a Paradigm of a New Technology: Its Impact on Regulation by the Food and Drug Administration. Journal of Parenteral Science and Technology 36: 248. | PubMed | ChemPort |
|
